CABA logo

Cabaletta Bio (CABA)

Profile

Full Name

Cabaletta Bio, Inc.

Ticker Symbol

CABA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 25, 2019

Indexes

Not included

Website

http://www.cabalettabio.com

Employees

161

Key Details

Price

$1.10(+1.85%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.34(-41.82% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.10
CABA price is $1.10

30-Day Relative Volume

0.55
CABA 30-day relative volume is 0.55

Price Performance

Price Today change

+1.85%
CABA price is up +1.85% today

Price YTD change

-51.54%
CABA price is down -51.54% since January 1st

Price 1-year change

-92.74%
CABA price is down -92.74% year-on-year

Price 3-year change

-39.56%
CABA price is down -39.56% over the past 3 years

Price Range

Price All-time high

$26.35
CABA price is currently -95.83% below its historical high of $26.35

Price 3-year low

$0.59
CABA price is currently +86.44% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$55.82M
CABA market capitalization is $55.82 million

Market cap 3-year change

+5.84%
CABA market capitalization is up +5.84% over the past 3 years

Market cap All-time high

$1.16B
CABA market capitalization is currently -95.19% below its historical high of $1.16 billion

Market cap sector rank

40.05%
CABA market capitalization is higher than 40.05% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.17%
CABA shares outstanding is up +5.17% year-on-year

Shares Outstanding 3-Year Change

+75.11%
CABA shares outstanding is up +75.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.47
CABA beta is 1.47

200-day SMA

$3.68
CABA price is currently -70.13% below its 200-day simple moving average

50-day SMA

$1.77
CABA price is currently -37.93% below its 50-day simple moving average

RSI

33.46
CABA 14-day relative strength index is 33.46

Volume

0.55
CABA 30-day relative volume is 0.55

ATR

$0.14
CABA average true range is $0.14

10-day Historical Volatility

112.23%
CABA 10-day historical volatility is 112.23%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CABA annual revenue value is unknown

Revenue Analysts estimate

$8.75M
CABA annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CABA annual revenue 1-year change is unknown

Revenue Sector rank

-
CABA annual revenue is unknown

EPS

EPS

-$2.34
CABA annual earnings per share is -$2.34

EPS Analysts estimate

-$2.29
CABA annual earnings per share is currently +2.23% higher than the consensus analysts' forecast

EPS 1-year change

-41.82%
CABA annual earnings per share is down -41.82% year-on-year

EPS Sector rank

35.7%
CABA annual earnings per share is higher than 35.7% of companies in Healthcare sector

Profit

Gross profit

-
CABA annual gross profit value is unknown

Gross margin

-
CABA annual gross profit margin value is unknown

Operating profit

-$125.14M
CABA annual operating income is -$125.14 million

Operating margin

-
CABA annual operating profit margin value is unknown

Net income

-$115.86M
CABA annual net profit is -$115.86 million

Net margin

-
CABA annual net profit margin value is unknown

Expenses

Total expenses

$125.14M
CABA annual total expenses is $125.14 million

Operating expenses

$125.14M
CABA annual total operating expenses is $125.14 million

Cost of goods sold

-
CABA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$27.94M
CABA annual SGA is $27.94 million

Depreciation and amortization

$1.71M
CABA annual depreciation & amortization is $1.71 million

Interest expense

$748.00K
CABA annual interest expense is $748.00 thousand

Income tax

-
CABA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$115.12M
CABA annual earnings before interest & taxes is -$115.12 million

EBITDA

-$113.41M
CABA annual EBITDA is -$113.41 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$185.05M
CABA annual total assets is $185.05 million

Non current assets

$18.37M
CABA annual long term assets is $18.37 million

Current assets

$166.68M
CABA annual total current assets is $166.68 million

Cash and cash equivalents

$163.96M
CABA annual cash & cash equivalents is $163.96 million

Accounts receivable

-
CABA annual accounts receivable value is unknown

Inventory

-
CABA annual inventory value is unknown

Liabilities

Total liabilities

$32.71M
CABA annual total liabilities is $32.71 million

Long term liabilities

$5.63M
CABA annual total long term liabilities is $5.63 million

Current liabilities

$27.09M
CABA annual total current liabilities is $27.09 million

Accounts payable

$4.92M
CABA annual accounts payable is $4.92 million

Debt

Total debt

$15.60M
CABA annual total debt is $15.60 million

Total debt 1-year change

+210.88%
CABA annual total debt is up +210.88% year-on-year

Long term debt

$5.63M
CABA annual long term debt is $5.63 million

Short term debt

$9.97M
CABA annual short term debt is $9.97 million

Equity & Capital

Shareholders equity

$152.34M
CABA annual stockholders equity is $152.34 million

Book value

$152.34M
CABA annual book value is $152.34 million

Retained earnings

-$349.10M
CABA annual retained earnings is -$349.10 million

Working capital

$139.59M
CABA annual working capital is $139.59 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$88.22M
CABA annual cash flow from operations is -$88.22 million

Cash from operations 1-year change

-64.75%
CABA annual cash flow from operations is down -64.75% year-on-year

Cash from investing

$47.29M
CABA annual cash flow from investing activities is $47.29 million

Cash from investing 1-year change

+310.63%
CABA annual cash flow from investing activities is up +310.63% year-on-year

Cash from financing

$11.68M
CABA annual cash flow from financing activities is $11.68 million

Cash from financing 1-year change

-93.78%
CABA annual cash flow from financing activities is down -93.78% year-on-year

CAPEX

CAPEX

-
CABA annual capital expenditures value is unknown

CAPEX 1-year change

-
CABA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$90.43M
CABA annual free cash flow is -$90.43 million

Free cash flow 1-year change

-66.74%
CABA annual free cash flow is down -66.74% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CABA annual gross profit margin value is unknown

Operating margin

-
CABA annual operating profit margin value is unknown

Net margin

-
CABA annual net profit margin value is unknown

ROA & ROE

ROA

-62.61%
CABA annual return on assets is -62.61%

ROE

-76.06%
CABA annual return on equity is -76.06%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CABA price to earnings ratio value is unknown

PE ratio Sector rank

-
CABA price to earnings ratio is unknown

PB Ratio

PB ratio

0.37
CABA price to book ratio is 0.37

PB ratio Sector rank

25.95%
CABA price to book ratio is higher than 25.95% of companies in Healthcare sector

PS Ratio

PS ratio

-
CABA price to sales ratio value is unknown

PS ratio Sector rank

-
CABA price to sales ratio is unknown

Enterprise value

Enterprise value

-$92.54M
CABA enterprise value is -$92.54 million

Enterprise value Sector rank

0.5%
CABA enterprise value is higher than 0.5% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.82
CABA EV/EBITDA is 0.82

EV/EBITDA Sector rank

74.35%
CABA EV/EBITDA is higher than 74.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.15
CABA annual current ratio is 6.15

Quick ratio

-
CABA annual quick ratio value is unknown

Leverage

Debt to equity

0.10
CABA annual debt to equity ratio is 0.10

Interest coverage ratio

-153.90
CABA annual interest coverage ratio is -153.90

Risk & Stability

Piotroski F-Score

-
CABA piotroski f-score value is unknown

Altman Z-Score

-
CABA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 1, 25 Wells Fargo
Equal-Weight
Apr 1, 25 UBS
Buy
Apr 1, 25 Morgan Stanley
Overweight
Apr 1, 25 HC Wainwright & Co.
Buy
Apr 1, 25 Guggenheim
Buy
Feb 18, 25 HC Wainwright & Co.
Buy
Jan 17, 25 HC Wainwright & Co.
Buy
Dec 20, 24 Evercore ISI Group
In-Line
Dec 19, 24 Wells Fargo
Equal-Weight
Nov 18, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

AKYA logo
Akoya Biosciences (AKYA)
GUTS logo
Fractyl Health (GUTS)
MGX logo
Metagenomi (MGX)
XTNT logo
Xtant Medical Holdings (XTNT)
NTRB logo
Nutriband (NTRB)
NOTV logo
Inotiv (NOTV)
OWLT logo
Owlet (OWLT)
KRON logo
Kronos Bio (KRON)
BEAT logo
HeartBeam (BEAT)
  • What is the ticker symbol for Cabaletta Bio?
  • Does Cabaletta Bio pay dividends?
  • What sector is Cabaletta Bio in?
  • What industry is Cabaletta Bio in?
  • What country is Cabaletta Bio based in?
  • When did Cabaletta Bio go public?
  • Is Cabaletta Bio in the S&P 500?
  • Is Cabaletta Bio in the NASDAQ 100?
  • Is Cabaletta Bio in the Dow Jones?
  • When was Cabaletta Bio's last earnings report?
  • When does Cabaletta Bio report earnings?
  • Should I buy Cabaletta Bio stock now?

What is the ticker symbol for Cabaletta Bio?

The ticker symbol for Cabaletta Bio is NASDAQ:CABA

Does Cabaletta Bio pay dividends?

No, Cabaletta Bio does not pay dividends

What sector is Cabaletta Bio in?

Cabaletta Bio is in the Healthcare sector

What industry is Cabaletta Bio in?

Cabaletta Bio is in the Biotechnology industry

What country is Cabaletta Bio based in?

Cabaletta Bio is headquartered in United States

When did Cabaletta Bio go public?

Cabaletta Bio's initial public offering (IPO) was on October 25, 2019

Is Cabaletta Bio in the S&P 500?

No, Cabaletta Bio is not included in the S&P 500 index

Is Cabaletta Bio in the NASDAQ 100?

No, Cabaletta Bio is not included in the NASDAQ 100 index

Is Cabaletta Bio in the Dow Jones?

No, Cabaletta Bio is not included in the Dow Jones index

When was Cabaletta Bio's last earnings report?

Cabaletta Bio's most recent earnings report was on Mar 31, 2025

When does Cabaletta Bio report earnings?

The next expected earnings date for Cabaletta Bio is May 15, 2025

Should I buy Cabaletta Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page